Abstract:Chronic obstructive pulmonary disease (COPD) is a heterogeneous inflammatory disease and eosinophils (EOS) participate in inflammation process. Acute exacerbation of COPD (AECOPD) is an inevitable trend in the development of the disease and has attracted widespread attention. In the present study, 108 hospitalized patients with AECOPD were collected and the levels of interleukin-13 and eosinophil cationic protein in the serum and sputum were measured to explore their clinical value in eosinophilic AECOPD patients. The patients were divided into an eosinophilic group (52 cases, 48.15%) and a noneosinophilic group (56 cases, 51.85%). The eosinophilic group had fewer acute exacerbations in the past year, shorter average hospitalization days, lower respiratory failure rate, mechanical ventilation utilization rate, and lower CAT and mMRC scores ( P < 0.05). The levels of interleukin-13 and eosinophil cationic protein in sputum in the eosinophilic group were higher than those in the noneosinophilic group ( P 0.05). The receiver operating characteristic (ROC) curves of sputum interleukin-13 and eosinophil cationic protein predicting peripheral blood EOS% ≥2% of AECOPD patients were statistically significant ( P < 0.05). The noneosinophilic group had a higher rate of rehospitalization due to acute exacerbation during the one-year follow-up, and there was no significant difference in mortality between the two groups. The results show that eosinophils in peripheral blood are a simple, convenient, and inexpensive index for assessing the condition and prognosis of AECOPD patients. Interleukin-13 and eosinophil cationic protein are involved in the pathogenesis of eosinophilic AECOPD and may be the new targeted anti-inflammatory therapies in the future. Impact statement Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is an inevitable trend in the development of the disease and eosinophils (EOS) participate in inflammation process. It is important to explore some relatively simple biomarkers in AECOPD which are useful to recognize the disease. In the present study, 108 hospitalized patients with AECOPD were collected and the levels of IL-13 and ECP in the serum and sputum were measured. The levels of IL-13 and ECP in sputum in the eosinophilic group were higher than those in the noneosinophilic group. Moreover, the noneosinophilic group had a higher rate of rehospitalization due to acute exacerbation during the one-year follow-up. The results show that eosinophils in peripheral blood are a simple, convenient, and inexpensive index for assessing the condition and prognosis of AECOPD patients. IL-13 and ECP are involved in the pathogenesis of eosinophilic AECOPD and may be the new targeted anti-inflammatory therapies.

Detection of inflammation-related indicators of AECOPD patients and its clinical significance

Determination of Biomarkers in Exhaled Breath Condensation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Clinical Implications

Serum Inflammatory Factor and Cytokines in AECOPD

Detection of interleukin-8 and interleukin-16 in induced sputum in patients with acute exacerbation of chronic obstructive pulmonary disease

Changes of Metailoproteinase-9, Tissue Inhibitor of Metalloproteinase-1 and Interleukin-8 in Elderly Patients with Chronic Obstructive Pulmonary Disease and the Effects of Different Drugs

Clinical Significance of Serum Procalcitonin and Hs C-reactive Protein Levels on AECOPD

Changes of procalcitonin and C-reactive protein in acute phase of chronic obstructive pulmonary disease and its si nificance

Study on airway inflammation in acute exacerbation of chronic obstructive pulmonary disease and relationship betweeu inflammation and lung function

The Detection and Clinical Signiflcance of Sfas and TNF-α in the Serums of Patients with Chronic Obstructive Pulmonary Disease

Study of Inflammatory Markers in Chronic Obstructive Pulmonary Disease

Change of Serum Inflammatory Cytokines Levels in Patients With Chronic Obstructive Pulmonary Disease, Pneumonia and Lung Cancer

Clinical significance of C-reaction in acute exacerbation of chronic obstructive pulmonary disease protein

Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

The Significance of TNF-α and C-reactive Protein in Chronic Obstructive Pulmonary Diseases

Role of TNF-α, sTNF-R55 and sTNF-R75 in inflammation of acute exacerbations of chronic obstructive pulmonary disease.

Alterations of Plasma Inflammatory Biomarkers in the Healthy and Chronic Obstructive Pulmonary Disease Patients with or Without Acute Exacerbation.

Clinical Significance of Detection of Inflammatory Markers in Induced Sputumfor COPD Patients with Positive Bronchodilation Test

Clinical significance of serum hypersensitive C-reactive protein, carbohydrate antigen 12 and interleukin-6 concentrations in AECOPD patients

Comparative Study of Cytokine Levels in Different Respiratory Samples in Mild-to-Moderate AECOPD Patients

A study of IL-6, IL-8, and TNF-α as inflammatory markers in COPD patients

Clinical value of IL-13 and ECP in the serum and sputum of eosinophilic AECOPD patients